TipRanks
Go Ultimate55% OFF

Alterity Therapeutics (ATHE) Q2 2024 Earnings Report

ATHE Q2 2024 EPS Results

Actual EPS
-$0.62
Consensus EPS
-$0.13
Beat/Miss
Missed by -$0.49
One Year Ago EPS
-$1.34

ATHE Q2 2024 Revenue Results

Actual Revenue
$0
Expected Revenue
$958.00K
Beat/Miss
Missed by -$958.00K
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2024
Date
02/28/2024
Time
Before Open
Conference Call
Wednesday, February 28, 2024
ATHE Upcoming Earnings

Alterity Therapeutics's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q2 2024 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

ATHE Earnings History

ATHE earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272027 (Q2)-0.03--0.38――
Feb 25, 20262026 (Q2)-0.23-0.38-0.5226.63% (+0.14)
Feb 28, 20252025 (Q2)-0.64-0.52-0.6215.53% (+0.10)
Feb 28, 20242024 (Q2)-0.13-0.62-1.3353.71% (+0.72)
Feb 28, 20232023 (Q2)-2.17-1.33-1.18-13.52% (-0.16)
Feb 28, 20222022 (Q2)―-1.18-2.8458.55% (+1.66)
Feb 25, 20212021 (Q2)―-2.84-2.67-6.29% (-0.17)
Feb 27, 20202020 (Q2)―-2.673.52-175.78% (-6.19)
Feb 28, 20192019 (Q2)―3.52-2.18261.26% (+5.71)
Aug 31, 20182018 (Q4)―-0.40-0.33-21.82% (-0.07)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed
Show More